GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $24,000 | -4.0% | 534 | -2.9% | 0.01% | +11.1% |
| Q4 2021 | $25,000 | +19.0% | 550 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $21,000 | -8.7% | 550 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $23,000 | +228.6% | 550 | +175.0% | 0.01% | +200.0% |
| Q1 2021 | $7,000 | -53.3% | 200 | -51.0% | 0.00% | -62.5% |
| Q4 2020 | $15,000 | 0.0% | 408 | -1.7% | 0.01% | 0.0% |
| Q3 2020 | $15,000 | +15.4% | 415 | +30.5% | 0.01% | 0.0% |
| Q2 2020 | $13,000 | 0.0% | 318 | 0.0% | 0.01% | -11.1% |
| Q1 2020 | $13,000 | +85.7% | 318 | +122.4% | 0.01% | +80.0% |
| Q4 2019 | $7,000 | +133.3% | 143 | +138.3% | 0.01% | +150.0% |
| Q1 2019 | $3,000 | +50.0% | 60 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $2,000 | 0.0% | 60 | 0.0% | 0.00% | +100.0% |
| Q3 2018 | $2,000 | -81.8% | 60 | -76.6% | 0.00% | -85.7% |
| Q2 2018 | $11,000 | +10.0% | 256 | -0.8% | 0.01% | 0.0% |
| Q1 2018 | $10,000 | +11.1% | 258 | -1.1% | 0.01% | 0.0% |
| Q4 2017 | $9,000 | – | 261 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |